CS
BDSI

Candriam SCA’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Candriam SCA’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-208,600
Closed -$1.16M – 671
2015
Q3 		$1.16M Buy
208,600
+28,600
+16% +$211K 0.03% 417
2015
Q2 		$1.43M Sell
180,000
-45,000
-20% -$387K 0.03% 400
2015
Q1 		$2.36M Buy
225,000
+65,000
+41% +$888K 0.05% 371
2014
Q4 		$1.92M Buy
+160,000
New +$2.43M 0.04% 357

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Candriam SCA's BDSI Position: Q4 2015 in Review

Candriam SCA sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2015, closing a stake of 208,600 shares — an estimated $1.16M sold.

Candriam SCA first reported a position in BDSI in Q4 2014 and held it in 4 quarters. The position peaked at $2.36M in Q1 2015. 126 funds tracked by Wall St. Rank hold BDSI as of Q4 2015.

  • Candriam SCA reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2015 after selling out during the quarter.
  • Candriam SCA sold 208,600 BioDelivery Sciences International, Inc. shares in Q4 2015, an estimated $1.16M.
  • Candriam SCA first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 4 quarters.
  • Candriam SCA's BioDelivery Sciences International, Inc. position peaked at $2.36M in Q1 2015.
  • 126 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2015.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.